great discomfort despite all medical measures including regulation of their activity, assistance in their emotional problems and medicinal treatment.
PLAN OF INVESTIGATION The first problem was to learn whether persistent hypothyroidism could be induced safely by one or more doses of I131. It is well known that thyrotoxicosis can be controlled by J131 with a reduction of the basal metabolic rate to normal. Three to eight millicuries are commonly used. The avidity of the normal thyroid gland for 1131 is much less, however; the uptake is usually 20-50 per cent of the administered dose, as indicated by urinary excretion, and averages 30 per cent as measured by external counting." Before the therapeutic studies of the present communication were undertaken, observations were made with gradually increasing doses in euthyroid patients in terminal state due to hemiplegia or other conditions such as carcinoma. The results of these studies indicated that persistent hypothyroidism could be induced by one or more appropriate doses without any toxic effects.'3 14 Since November 1947 we have induced persistent hypothyroidism in the 18 consecutive cardiac patients of the present report in whom the duration of the follow-up is sufficient for clinical evaluation of the therapeutic results.
METHODS OF STUDY
The clinical appraisal of the post-treatment as well as of the pretreatment condition of each patient was carried out independently by several observers. We also have evaluated the pretreatment as well as the post-treatment condition of our patients by as many objective criteria as possible. Detailed clinical and laboratory studies were performed before, and at frequent intervals after treatment. With a few minor exceptions, the treatment of cardiac disease in each patient was the same after treatment as before treatment.
Routine examinations of the blood and urine, electrocardiograms and roentgenograms of the chest taken at a distance of 7 feet were performed before treatment and at frequent intervals after treatment. Blood for cholesterol measurements was drawn from the antecubital vein with minimal stasis after a fast of fourteen hours or more. Measurements of serum cholesterol were made in duplicate by the method of Myers and Wardell,'5 using the apparatus for continuous extraction described by Ling.l The averages of the duplicate determinations, which checked within 5 per cent, have been reported. Where the clinical state of the patient indicated, special studies of the blood were performed. These included nonprotein nitrogen, glucose, total protein, calcium, corrected sedimentation rate, and prothrombin time.
The basal metabolic rate, the vital capacity of the lungs and its subdivisions were measured with a Collins Benedict-Roth apparatus. Patients with orthopnea were allowed to lie in a semirecumbent position. On each occasion, measurements were made in duplicate or triplicate and were repeated before treatment until it was evident that the patient had attained the basal state. The Dubois normal standards as modified by Boothby and Sandiford were used. 17 The venous pressure was measured by the direct method of Moritz and Tabora.l8 When possible, the readings were obtained with the patient recumbent, the right auricle being assumed to be 5 cm. below the level of the fourth costochondral junction. When orthopneic, the patient was allowed to sit up at an angle of 45 degrees, the right auricle then being assumed to be 2.5 cm. below the fourth costochondral junction.
The arm to tongue circulation time was performed with sodium dehydrocholate (Decholin) according to the methods of XVinternitz, Deutsch Many of our patients with angina pectoris were too ill to be subjected to an exercise tolerance test.
When the hazard was not considered significant and when the patient could undertake the necessary effort, exercise tolerance tests as described by Rise- man and Stern24 were performed before and after treatment.
DOSAGE, RETENTION AND SIDE EFFECTS OF J131
Each patient has received orally a total of 25.5 to 150 millicuries (table 1) , carrier free, in single or divided doss, of which a total of 7.3 to 39 millicuries has been retained in the body during the following seventy-two hours. The largest single dose has been 56 millicuries. The average total dose has been 54.4 millicuries; the average retention, 17.9 millicuries. The patients have experienced no serious toxic symptoms; in approximately two-thirds of the patients, transitory thyroiditis characterized by slight to moderate pain and tenderness over the thyroid with pain on swallowing has been present one to fourteen days following the initial therapeutic dose. In only one instance (Case 1) was a subsequent therapeutic dose attended by clinical thyroiditis. Thus, transitory thyroiditis occurred twelve times after thirty-one therapeutic doses given to the 18 patients. It was mild seven times, moderate four times and severe once. In 7 of the 18 patients, clinical thyroiditis did not occur. Radiation sickness has not been observed. Repeated examinations of the blood and urine revealed no toxic effects.
CLINICAL DESCRIPTION OF THE EIGHTEEN
PATIENTS AND RESULTS The course of angina pectoris and congestive failure is often irregular and characterized by periods of unexpected exacerbation and remission. We have, therefore, selected only patients who, despite marked restriction of activities for many months or years, showed evidence of continued incapacity after having received all standard forms of therapy and in whom remissions of the disease were absent or who continued to suffer signs and symptoms even during periods of slight remission.
The patients with angina pectoris (table 2) suffered characteristic attacks on effort or emotion and continued to have several or many attacks a day on slight exertion such as walking short distances, bending to tie shoe laces or walking one flight of stairs; many were awakened from sleep nightly or several times a week, and had attacks after eating; several had attacks of cardiac asthma. None of the patients had been able to carry on gainful occupation except Case 7 , doing light work a few hours a day, and Case 11, as an upholsterer, several hours a day. The severity of cardiac involve- In some of the patients of this series, the probability of achieving a worthwhile result was admittedly small. Thus, Patient 5 had already suffered two attacks of acute myocardial infarction and several other episodes of prolonged excruciating pain but without progressive characteristic electrocardiographic changes. Similarly, Patient 18 had shown a rapidly progressive course of congestive failure with multiple embolic episodes. In all patients included in this report, reliable information regarding the characteristics and severity of the clinical course was available. Some patients had been observed for years in the cardiac clinic of the Beth Israel Hospital and on the wards; others were referred by highly competent physicians who placed their records at our disposal. Each patient was appraised independently by several of us before a decision was reached; in many instances, our appraisal was based on observation and study of the patient, including exercise tolerance and other tests, over a period of weeks or many months before radioactive iodine therapy was instituted.
No patient was chosen whose prognosis for life was good. In each instance the procedure was explained to the patient with a full account of its experimental status and the necessity for frequent follow-up studies. In some patients the treatment was inaugurated while they were still No patient showed positive evidence of hyper-or hypothyroidism before treatment. In addition to the clinical criteria, the following indices revealed normal thyroid function: the basal metabolic rate, serum cholesterol, and, in some instances, the serum protein-bound iodine. Tracer doses of J131 were administered and in all cases the percentage of urinary excretion was that observed with normal thyroid function. In patients with congestive failure, the urinary excretion is lower than that observed in edema-free individuals. Direct measurements of the thyroid uptake in patients with congestive failure have revealed uptakes in the euthyroid range.
The patients selected had diverse types of cardiovascular disease i.e., arteriosclerotic heart disease with congestive failure, arteriosclerotic heart disease with angina pectoris, arteriosclerotic heart disease with hypertension and paroxysmal dyspnea, rheumatic valvular heart disease with normal rhythm or with auricular fibrillation.
To obtain patients who met these requirements, only certain patients were selected from among the larger group with intractable heart disease. Some rejected patients failed to give sufficient objective confirmation of their incapacity when carefully studied; others were afflicted with associated diseases (such as bronchiectasis with advanced pulmonary emphysema, renal disease, cirrhosis of the liver, cerebral arteriosclerosis, active rheumatic fever, subacute bacterial endocarditis) which would render evaluation of the therapeutic result difficult. In others, the April 27, 1948 . One year prior to I"31 therapy, attacks of substernal pressure on exertion and emotion were first noted. He was hospitalized for eight months before treatment because of "clawing, tearing" substernal pain with momentary loss of consciousness, due to probable acute myocardial infarction. The anginal attacks increased in severity and frequency, lasted from one to ten minutes and were relieved by nitroglycerine. He had been unable to work for the previous nine months and had been restricted largely to the house because walking even a hundred feet precipitated an attack. He was awakened by anginal attacks, often suffering three or four episodes nightly. He noted increasing dyspnea and was uncomfortable unless he used two pillows. In the month prior to I131 therapy, he had used over 500 tablets of nitroglycerine. During his illness, he had received the following treatment: theobromine sodium acetate, potassium iodide, sedatives, quinidine, atropine; nitroglycerine alone was of slight help. There ;. and there was some puffiness below the eyes. On August 9, 1948, five and a half months after J131, the patient showed definite evidence of myxedema. He had maintained his cardiac improvement. At this time, he was instructed to take thyroid 6 mg. daily, and later this was increased to 18 mg. However, he continued to complain of symptoms due to myxedema, and it was discovered that the patient had failed to take thyroid as ordered. In May 1949, the patient was seen because of severe pain in the right upper quadrant, due to herpes zoster. At this time he was having no angina pectoris and no symptoms of congestive failure. He was taking no cardiac medication or thyroid. He had no dyspnea, orthopnea, ankle edema and suffered minimal discomfort from myxedema. X-ray examination showed the heart to be greatly dilated with small amplitude of contraction. The heart rhythm was grossly irregular, rate 57 to 110, and the electrocardiogram showed auricular flutter with varying auriculo-ventricular block. The serum cholesterol was 399 mg. per cent.
Comment: This 72 year old male, with a ten year history of angina pectoris and an eight year history of congestive heart failure, showed striking improvement following the administration of radioactive iodine with remission of all his cardiac symptomatology. Five and one-half months after treatment, he went into frank myxedema, the symptoms of which were troublesome, but the patient refused to take thyroid as ordered. When last seen, fifteen months after J131, he had maintained his cardiac improvement and was only minimally troubled by myxedema. He has continued to refuse to take thyroid.
Case 5.-Severe, frequent angina pectoris, two years. Two attacks of acute myocardial infarction and many other attacks of excruciating and prolonged cardiac pain without electrocardiographic changes, i.e., "coronary failure." Myxedema induced by two doses of I1's with marked relief of angina pectoris. Myxedema controlled by 24 The serum cholesterol, the basal pulse rate, the basal metabolic rate and the clinical course following the administration of two doses of 42.5 and 25.5 millicuries of 1"31. To conform to the activity of the millicurie used by the Bureau of Standards and also used throughout this paper, the millicurie stated in the above figure should be multiplied by the factor of 1. 1942 , he noted the onset of dyspnea on exertion, and angina pectoris on exertion and emotion, relieved by nitroglycerine. There was a past history of recurrent, acute pyelonephritis. Physical examination revealed the blood pressure 194/128, cervical venous engorgement, and fine basal rales. The liver was four fingers below the costal margin and there was slight pitting edema of both ankles. On rest, digitalization, theobromine sodium acetate and phenobarbital, he noted some improvement in dyspnea. Attacks of angina pectoris continued and he was unable to work.
In June 1947 he suffered an exacerbation of congestive failure with orthopnea and peripheral edema. Walking even short distances produced dyspnea and palpitation. Although house bound, he suffered two to five attacks of angina pectoris weekly.
On a chair-and-bed regimen, digitalis and a low salt diet, purines and nitroglycerine for the three months before 1131 therapy, there were continued peripheral edema, dyspnea on climbing one flight of stairs, orthopnea and palpitation. Attacks of angina pectoris continued unchanged.
Pretreatment Physical Examination. The neck veins were distended, the lungs were clear. The heart was enlarged, the rhythm regular. The blood pressure was 228/118. The liver was percussed three fingersbreadth below the costal margin. There was moderate pitting edema of the legs.
Pretreatment Laboratory Examination. (See table   2 .) The blood was normal. The urine showed a 1 + albumin content and 0-3 rel blood cells in the sediment. The specific gravity was 1.016. The electrocardiogram was consistent with left ventricular hypertrophy. On x-ray examination the heart was markedly enlarged to the left, the aorta dilated and the hilar shadows and lung markings increased, indicating left ventricular hypertrophy and dilatation and moderate pulmonary congestion. During the next month, the nodule gradually decreased in size and disappeared. In April 1949, ten weeks after the second dose, the patient definitely experienced fewer episodes of squeezing precordial pain and they were less severe. There was also a diminution in palpitation. The serum cholesterol had risen 100 mg. per cent from the previous level. Six weeks later, four months after the second dose, the patient noted further marked improvement and required nitroglycerine only once every two to three weeks. Furthermore, the urinary reductions of Benedict's solution were negative more frequently than ever before, and the Diabetic Clinic in consequence reduced the daily dose of insulin from 56 (table 1) . Two months later the basal metabolic rate was -11 per cent; the patient observed he had the same number of attacks but they were less severe. Nocturnal attacks decreased from nightly to only once a week and he could walk a little farther without developing pain. Exercise tolerance test was unchanged.
Four months after J131 the basal metabolic rate decreased to -17 per cent. The serum cholesterol rose to 328 mg./100 cc. The patient required only 2 to 5 nitroglycerine tablets a day and none at night. He no longer had attacks at meals, but climbing stairs continued to induce angina pectoris. During the next month, frank myxedema occurred; the metabolism was -27 per cent, the cholesterol 400 mg. per cent. During this period there was marked diminution of angina on effort. Nitroglycerine tablets, 3 daily, were used only in an attempt to alleviate intermittent claudication. Exercise tolerance test was not of value because of the leg pain. Thyroid, 24 to 36 mg. a day, did not control the symptoms of hypothyroidism. Despite the fairly marked improvement in angina pectoris as manifested by diminution in the number of attacks from ten to fifteen to only one to two a day, the absence of night pain, and the ability to work several hours a day without pain, the patient was unhappy over the degree of discomfort arising from myxedema. Hypertension was first noted seven years before 1131. Five years before treatment, she was hospitalized because of increasing dyspnea, orthopnea, substernal oppression, weakness, and weight loss of three month's duration. The diagnoses were hypertension, hypertensive heart disease, congestive heart failure, and thyrotoxicosis. The patient was treated with digitalis, low-salt diet and potassium iodide with incomplete relief. Treatment with thiouracil was followed by icterus, pruritis and diarrhea; biopsy of the liver revealed acute bile stasis; slow recovery followed omission of the drug.
Four years before I131 treatment, dyspnea, orthopnea, weakness and weight loss required a fourth hospital admission. Hemithyroidectomy was performed. The recurrent laryngeal nerve was cut and right cord paralysis resulted.
Potassium iodide was administered and continued, but twenty months before J131 treatment, readmission was necessary because of acute pulmonary edema. Following recovery, three basal metabolic rate determinations were ±0 per cent. Eight months before I131 treatment, potassium iodide was omitted. Two months before 1131, she noted marked dyspnea on slight exertion and anterior chest pain radiating to the left arm on moderate exertion, often relieved by nitroglycerine. During the two months before J131, she also had had three or four episodes of acute pulmonary edema. Despite markedly restricted activity, digitalis, low salt diet and xanthines, symptoms continued.
Pretreatment Physical Examination. The patient was dyspneic; the neck veins were distended; blood pressure was 230/90. There was no tremor or tachycardia; basal pulse rate was regular, 62 to 66. The heart was markedly enlarged to the left; a basal systolic but no diastolic murmur was heard. There was slight peripheral edema.
Pretreatment Laboratory Examinations. (See table   3 .) The blood, urine and stool were normal. Nonprotein nitrogen was 39 mg. per cent; total protein was 6.5 grams per cent. On x-ray examination, the heart was enlarged and the lung markings were increased. Case 18 .-Rheumatic heart disease, mitral stenosis and insufficiency, aortic stenosis and insufficiency, dyspnea on exertion for twenty years, auricular fibrillation for fifteen years, progressive congestive heart failure for six years with two admissions in the three months before treatment for marked congestive heart failure despite optimal therapy. M\yxedema induced with one dose of 1131. Temporary but no lasting worthwhile improvement of congestive failure.
Pretreatment History. N. A., a 43 year old woman, B.I.H. s71514, received 39 mc. IJ3' on November 9, 1948. Twenty-five years previously polyarthritis occurred and there was intermittent recurrence during the next ten years. Twenty-one years ago she noted dyspnea on marked exertion with occasional ankle edema, and for the past fifteen years irregularity of the pulse. Twelve years prior to J131 treatment, acute paroxysmal dyspnea was experienced, and the diagnosis of rheumatic heart disease was made. Six years ago exacerbation of rheumatic fever, and again later that same year, mild congestive failure subsequent to a respiratory infection required hospitalization. She was subsequently followed in the Cardiac Clinic, and maintained on digitalis and ammonium chloride. She had moderate dyspnea, orthopnea, occasional paroxysmal nocturnal dyspnea and mild ankle swelling. Three years ago she was hospitalized for increasingly severe congestive failure and hydrothorax and again three months before treatment because of congestive heart failure, polycythemia vera and multiple cerebral episodes with transient hemiparesis and aphasia.
Following discharge she experienced episodes of paroxysmal dyspnea, severe orthopnea, suffered marked dyspnea on minimal effort and gained 16 pounds despite a salt-free diet, digitoxin and a weekly injection of a mercurial diuretic. She was only barely able to do light housework. One month before treatment she was again admitted to the hospital with severe congestive failure, accompanied by persistent abdominal swelling. An (See table   3 .) iIost urine specimens revealed a specific gravity of 1.017 with 2 to 3 plus albumin, 10 to 12 white blood cells and occasional red blood cells. The hemoglobin was 13.9 grams, red blood count 4.5 million, white blood count 6,850 with a normal differential count. The nonprotein nitrogen was 38 mg. per cent, the icteric index 13-19, total protein 7.8 Gm. per cent; normal albumin/globulin ratio. On x-ray examination the heart was markedly enlarged to the right and to the left, the transverse diameter being 17 cm.
The electrocardiogram showed auricular fibrillation, multiple ventricular extrasystoles, right axis deviation and was consistent with left and right ventricular hypertrophy. In the seventy-two hours following a tracer dose of I's', 58 per cent was excreted in the urine.
Post-treatment Clinical Course. On November 9 1948, 39 me. of J131 were administered (table 1) .
Four xveeks later, she suffered an embolus to the left popliteal artery and left kidney. She recovered gradually without sequelae.
Ten weeks after Il3l, the basal metabolic rate was DiscussION OF RESULTS The accurate evaluation of every clinical therapeutic measure is beset by the possibly favorable effect of suggestion and spontaneous improvement due to changes in the natural history of the condition. Throughout this investigation we have tried to reduce such errors to a minimum. Practically all patients were treated on an ambulatory basis, obviating the possible effect of prolonged bed rest and hospitalization. Following administration of F"3, hypothyroidism appeared only after five weeks to five months, and could not be anticipated by either the patient or the observers. It was particularly impressive to have the patient report, after receiving F", that for the first time in months or years he felt definitely improved, and then to find definite improvement on physical examination. Concomitantly, the laboratory reports of the basal metabolic rate measurements and serum cholesterol determinations indicated the inception of hypothyroidism ( fig.  1, Case 3) . Conversely, some patients, during the period in which they gave evidences of thyroiditis as manifested by pain and tenderness with increased heat over the thyroid area, noted their condition was definitely worse. In some of these individuals the basal metabolic rate was slightly elevated (figs. 1 and 2, Cases 3 and 5). We have observed in such instances an elevation of the serum protein-bound iodine measurement. Several patients during this time also exhibited slight tachycardia and increased nervousness and sweating indicative of mild hyperthyroidism. As clinical improvement became evident, the degree of improvement generally was proportional to the degree of hypothyroidism. This correspondence between metabolic levels and clinical status was manifested in twenty-six episodes in the 18 patients.
The observed relation between the metabolic rate and clinical improvement is a clear verification of the rationale of this procedure which has been elucidated in previous communications,1 2 28, 29 and, therefore, will be described only briefly. Circulation and metabolism are two closely related fundamental characteristics for, clearly, metabolic activity of the tissues would be impossible without adequate blood supply. The normal metabolic level of the body is maintained by the normal thyroid. With decreased function of the thyroid, the metabolic level is decreased until, in the absence of thyroid function, the basal metabolic rate is approximately 40 per cent below normal. At these levels the cardiac work, as indicated by the diminished output and the slower speed of blood flowv,l' 30 is decreased; the decrease in circulation is, indeed, even more than the metabolic rate would indicate, for the arteriovenous oxygen difference is widened. It was thought, therefore, that the diseased heart, while unable to meet the demands of normal metabolic and circulatory requirements, nevertheless might be able to meet the reduced needs in hypothyroidism.
Clinically, it has long been known that subtotal thyroidectomy in thyrocardiac patients usually accomplishes permanent lowering of the basal metabolic rate from abnormally high levels to a normal level, with coincident improvement in angina pectoris and congestive failure as the demands on the heart are lessened.3" 33 Conversely, when thyroid is administered to patients with spontaneous myxedema, angina pectoris34136 and the signs and symptoms of congestive failure3-38 not infrequently develop because of the increased demands on the heart.39"4 It is well recognized that exercise, emotion and other factors which increase cardiac work tend to aggravate angina pectoris and congestive failure. The enforcement of diminished activity or complete bed rest benefits patients by reducing the demands on the heart. The use of sedatives and the action of digitalis in reducing the ventricular rate in auricular fibrillation have a similar effect.
The induction of hypothyroidism for the treatment of angina pectoris and congestive failure is an extension of this therapeutic principle. In lessening the demands on the heart in patients with intractable heart disease by purposefully inducing myxedema, a diminution in cardiac work is accomplished. Since the heart in hypothyroidism performs less work and starts at a lower level of oxygen consumption, it can withstand a greater increment of work before reaching the upper limit of its work capacity. This upper limit of work capacity in patients with congestive failure is imposed by the presence of valvular disease, hypertension, or injury because of rheumatic myocarditis or prior myocardial infarction. In angina pectoris, many of these factors, as well as the limitation of blood supply by the relatively fixed arteriosclerotic coronary vessels, are operative; the coronary circulation cannot increase in accordance with the increased needs of the heart. Relative anoxemia results, and angina pectoris occurs.
The hypothyroid state also possibly exerts a favorable effect in several other directions. When patients are frankly myxedematous with basal metabolic rates of -30 to -40 per cent they are often irritable and nervous but, on receiving small doses of thyroid to maintain them at a level of -13 to -25 per cent, they are frequently more placid and even-tempered emotionally than before treatment, though mentally as acute as formerly. In an occasional patient, such as J. K. (Case 3) , this factor may be significant; the patient stating that all his life prior to treatment he was prone "to fly off the handle whereas now I am more eventempered." Accordingly, after the induction of myxedema, small doses of 6 to 100 milligrams of thyroid are administered daily to maintain all patients at a level, usually of -15 to -25 per cent, at which they experience the least discomfort from myxedema and the maximum relief from their cardiac symptoms.
The question naturally arises whether the increased emotional stability in some of our patients is due to a lessened sensitivity to epinephrine. Previous studies42 of the effects of known concentrations of epinephrine administered intravenously before total thyroidectomy and at various metabolic levels after operation demonstrated that the response of blood pressure, cardiac rate, oxygen consumption and respiration remained unchanged as long as the basal metabolic rate was not lower than -30 per cent and the patient was free from the distressing symptoms of myxedema. At levels below that at which our patients are maintained, a decreased response of the blood pressure and the heart rate to epinephrine became manifest in some instances. These observations on the unaltered sensitivity to epinephrine at the metabolic levels maintained in our patients do not preclude the possibility, however, that a decreased secretion occurs in the hypothyroid state.
THE EFFECT OF HYPOTHYROIDISM ON ANGINA PECTORIS Angina pectoris has been strikingly lessened or abolished in 8 of the 13 patients with intractable cardiac pain (table 2). The duration of angina pectoris in these 8 patients was from one to ten years and averaged three years, eight months. All of these patients had experienced cardiac pain on exertion and many had attacks on emotion; several had pain which came on at rest and even during sleep. The improvement has been particularly striking in five patients (Cases 1 to 5). These patients are able to undertake considerably more exertion than formerly with only occasional or no attacks of angina pectoris. Cases 1 and 2 are gainfully employed, whereas prior to treatment they had been completely incapacitated for years because of angina which was precipitated by the slightest effort. In the other 3 of the 8 patients, the result has been definitely worthwhile according to the appraisal by the patient and by us. In addition to the foregoing 8 patients, Case 14, incapacitated primarily because of congestive failure, also suffered angina pectoris on moderate exertion. With improvement in the congestive failure, angina pectoris no longer occurs.
In the remaining 5 of the 13 patients with angina pectoris, the therapeutic result has not been striking. In Case 9, angina pectoris was relieved for nine months but has since relapsed to pretreatment status. In the 4 patients (Cases 10, 11, 12 and 13) in whom the therapeutic result was not considered worthwhile, angina pectoris was either strikingly lessened or abolished when the patients exhibited the clinical and laboratory evidences of myxedema. It Patient 15 , orthopnea is no longer present, ascites has remained absent, the liver is no longer palpable, cyanosis has disappeared and the vital capacity of the lungs has increased from 2200 cc. to 3650 cc. The patient is able to engage in useful activity for the first time in one and one-half years.
In the 2 patients in whom a worthwhile therapeutic effect could not be ascribed to J131 therapy, definite improvement of congestive failure occurred in one (Case 17) but this may have been due to improvement in the concomitant rheumatoid arthritis. In the other patient (Case 18), definite temporary improvement was evident for approximately one month followed by relapse to her pretreatment status consequent to small doses of thyroid.
In addition to these 5 patients, symptoms and signs of congestive failure were present in many of those incapacitated primarily because of angina pectoris. Congestive failure had been noted for ten years in Patient 4, for five years in Patient 6 with episodes of peripheral edema, pulmonary congestion, recurrent paroxysmal nocturnal dyspnea and orthopnea. Paroxysmal (lyspnea and attacks of acute pulmonary edema had also occurred in Cases 2 and 3. In all of these patients the significant improvement in angina pectoris was associated with comparable improvement in the manifestations of congestive failure, the signs and symptoms being impressively relieved or entirely dissipated.
EFFECT O-N ASSOCIATED DISEASES
Diabetes mellitus was present in 2 patients (Cases 8 and 12). In one patient, the disease was mild an(1 require(l no insulin; no change could be discerned after treatment. In the other patient, 56 units of protamine and 20 units of regular insulin were required daily before treatment, compared to 50 and 12 units after treatment; the control of glycosuria was better after treatment. While not as striking a reduction in insulin requirement as observed in some cases after total thyroidectomy, the amelioration of diabetes mellitus is in accordance with our previous experience,43
Advanced chronic nephritis was present in one patient (Case 15) . The striking improvement in congestive failure in this patient was not followed by any striking change in the 1)loo10 nonprotein nitrogen.
CHANGES IN OBJECTIVE CLINICAL MEASURE-MENTS AFTER INDUCTION OF HYPOTHYROIDISM
T'he basal metabolic rate has been significantly lowered in every patient thus far treated. The decrease in metabolic rate has become evident five weeks to five months after treatment. In some instances, no effect has been noted after the initial dose of Jl3l and one or more additional doses were necessary. In most patients, a state of frank myxedema was permitted to become manifest before thyroid medication was administered, but in certain patients an optimal hypothyroid state has been induced and thyroid medication was not necessary. When patients are in marked myxedema, the discomfort not The velocity of bloodflow also shows significant changes. Previous studies1' 4 demonstrated that the speed of blood flow is slowed in myxedema. In the usual euthyroid patient with congestive failure, the blood flow is also slowed but becomes more rapid as compensation is regained. In accordance with these studies, we have observed that patients with angina pectoris but no congestive failure (Cases 3, 5, 7) showed a slowing in velocity of blood flow as hypothyroidism was induced. In (Case 5) or -24 per cent (Case 3) without any significant discomfort; others must be maintained at relatively high levels such as -15 per cent (Case 14) . Patients 1, 2, 3, 5 and 15 are maintained in the hypometabolic state with little or no discomfort, whereas others (Cases 11, 12 and 13) are uncomfortable at similarly decreased levels. The explanation of the considerable individual differences is not clear. The distress of myxedema which requires thyroid therapy includes the following: lethargy and sleepiness, stuffiness of the nose and ears, stiffness and ache of the muscles and joints, paresthesias, weakness of the legs, irritability and depression, puffiness of the eyes and face.
In each instance, thyroid dosage must be adjusted to maintain the patient at the lowest level at which he experiences the maximum relief from his cardiac disease and the minimum discomfort from myxedema. In certain patients (Cases 11, 12 and 13), this has not been possible, the patient showing little or no improvement over his pretreatment status when sufficient thyroid was administered to obviate the discomfort. In general, a pretreatment basal metabolic level of -10 per cent or higher permits a greater leeway.
Each of the present authors has been impressed with the fact that at comfortable levels of hypometabolism, usually -15 to -25 per cent, the patients are bright and alert rather than mentally lethargic. THE QUESTION OF "THE MYXEDEMA HEART" As in previous studies, particular attention has been devoted to the appearance of evidence of the signs or symptoms of the so-called "myxedema heart." Observations of the heart in spontaneous myxedema34 [46] [47] [48] [49] [50] [51] [52] Krantz,34 however, studied a total of three hundred patients with myxedema and concluded that heart function is rarely, if ever, impaired. From a review of the literature and a comprehensive study of 30 additional cases at the Massachusetts General Hospital, Lerman, Clark and Means49 concluded that "myxedema heart" in the sense of heart failure occurs rarely, if at all-an opinion likewise expressed by Christian.40' 60 Our own observations are in accordance with the latter findings; an increased cardiac silhouette or area of percussion dullness, decreased voltage of the electrocardiogram and less forceful pulsations on fluoroscopy have been observed in some of our subjects. But "myxedema heart" in the sense of a condition aggravating or precipitating attacks of angina pectoris or congestive failure did not develop in our cardiac patients. On the contrary, with the appearance of such changes, striking clinical improvement has been witnessed. In some patients with congestive failure, the cardiac silhouette became smaller, the disappearance of the dilatation of the failing heart offsetting the effect of myxedema on the heart. We believe that the designation, "the heart in myxedema," is more accurate than the term "myxedema heart" as employed by Zondek55 The many advantages of inducing hypothyroidism by radioactive iodine rather than total thyroidectomy may be summarized as follows: Surgical interference with its inevitable mortality, pain and discomfort is obviated. Prolonged hospitalization is not necessary. Some of our patients have been studied in the hospital for brief periods to facilitate our research; others, however, have been treated wholly on an ambulatory basis. In the evaluation of therapeutic benefit, the possible effect of bed rest in hospital need not be considered after radioactive iodine therapy. Total thyroidectomy, like subtotal thyroidectomy, entails possible damage to the parathyroids and recurrent laryngeal nerves, and the possibility of aberrant or residual thyroid tissue not readily seen or removed at operation. Immediately following total thyroidectomy, amelioration or disappearance of the pain of angina pectoris was observed due to the severance of sensory nerve pathways.66' 67 This early relief is not enjoyed after 1131 therapy, but on the other hand, the therapeutic effect of hypothyroidism per se can be more accurately observed, uncomplicated by this early relief, by the period of hospital bed rest, and by the possible effect of suggestion. The irregular interval of five weeks to five months after 1131 treatment, before hypothyroidism becomes evident, is an additional safeguard against the possible effect of suggestion. The time at which hypometabolism and clinical improvement occurs cannot be foretold by the patient or the physician; the clinical improvement, first noted by the patient and later found to be coincident to the inception of hypometabolism when the results of the serum cholesterol and basal metabolic determinations are made available, is consequently the more impressive.
In the doses needed to We believe this procedure should still be considered in the investigative stage and, therefore, should be reserved for those patients who in spite of all available therapeutic medical measures remain cardiac invalids. Before radioactive iodine is administered, the patient's condition should be improved to the fullest possible extent by prolonged and adequate treatment in order that the effect of J131 therapy may be evaluated as clearly and as accurately as possible.
Patients whose incapacity is due in significant measure to other conditions which will not be helped by the hypometabolic state and which may even be adversely affected should not be accepted for treatment. Included in this category are patients with emotional instability, particularly with depressions (see Cases 7, 10 and 17), patients with intermittent claudication of the legs (Case 11), patients with rheumatoid arthritis (Case 17) or active rheumatic fever, and patients prone to embolic phenomena which may dominate the clinical situation at any time (Case 18 therapy in any patient with initial metabolic levels below -15 per cent. The one patient (Case 10) who constitutes the exception was relieved of angina pectoris when the basal metabolic rate was -42 per cent but experienced no worthwhile improvement when maintained at -25 per cent, which was practically identical with that before treatment.
In general, our results with patients with angina pectoris have been more striking than in those with congestive failure. In angina pectoris one is dealing with a solitary symptom which, when relieved or abolished, frees the patient from disability. In patients with congestive failure one usually can anticipate only partial relief from disability. If bedridden continuously with congestive failure, they may enjoy freedom from failure when up and about. If congestive failure develops on only mild exertion, they may enjoy a moderate increase in activity. With such increased activity, relief of dyspnea, paroxysmal nocturnal dyspnea, pulmonary edema and diminished frequency or abolition of injections of mercurial diuretics may be observed.
It may be helpful to state our present concept of a favorable candidate for J131 therapy. The patient is between 40 The blood pressure is normal or slightly elevated. The basal metabolic rate is above -10 per cent. Examinations of the blood, urine and stools reveal normal findings. Although a good therapeutic result is not invariable, our experience demonstrates that well over half of such patients will experience worthwhile improvement.
PRE-AND POST-TREATMENT MANAGEMENT Radioactive iodine therapy for euthyroid cardiac patients, as previously stated, is to be regarded as an adjunct; the patient's cardiac condition must continue to be treated with the same painstaking care previously exercised. Before administering 1131, we have placed the patients on a low iodine diet and have assured ourselves that stable iodine has not been received by the patient. The most common sources of iodine are in cough or other medicines, gall-bladder dye, antiluetic drugs or iodized salt. We have explained the present investigative nature of this form of therapy to our patients and have administered tracer doses of 100 or 150 microcuries. A dose of approximately 40 millicuries in our experience is uisually effective in producing myxedema. To obviate the discomfort of possible thyroiditis, we recently have increased the total dose slightly and administered it in three divided doses at ten-to fourteen-day intervals. Twenty-four hourly collections of urine for three days following the tracer dose and again following each therapeutic dose have been measured for Jl3l content. In some patients, the amount of 1131 uptake by the thyroid has been measured directly by the method devised by one of us."2
If the patient has a thyroid nodule, the possibility exists that 1131 will destroy the normal thyroid tissue, following which the adenoma may take on function. In at least one instance, however, the single initial therapeutic dose affected the nodule as well as the normal tissue with resultant hypothyroidism.
In other patients, additional doses may be required to effect destruction of the adenoma.13
With the appearance of hypothyroidism, it has been our practice to permit frank myxedema to develop in order to learn the effects of J131 uncomplicated by other medication. It is possi-ble that patients may be safeguarded from some of the unpleasant symptoms of myxedema by administering small doses of thyroid before they reach markedly lowered levels of metabolic rates below -30 per cent. In a patient recently treated, but not included in this series, we have administered 6 mg. of thyroid daily after the basal metabolic rate had declined from -5 per cent to -20 per cent, at which latter level the patient was conspicuously relieved of attacks of angina pectoris but showed no discomfort from hypothyroidism.
Patients with myxedema are remarkably responsive to small doses of thyroid. The optimum metabolic rate level for each patient varies somewhat but is usually between -15 and -25 per cent. Fifteen milligrams of thyroid is usually sufficient to maintain this level, but in some patients only 6 mg. is necessary. Depending on the metabolic rate level and the severity of the symptoms of myxedema, if present, it has been our practice to initiate thyroid medication in doses of either 6 or 12 mg. daily (1/10 to 2/10 grain). In some patients, higher doses of thyroid are necessary, as in Case 14 who was maintained by daily thyroid doses of 90 mg. at a level of -15 per cent, compared to a pretreatment level of +20 per cent. In general, it has been our practice to begin with small doses and to raise the amount administered in accordance with the patient's symptomatology, basal metabolic rate measurements, and at times determination of the serum cholesterol concentration. All patients should be seen at least once a month, since it is entirely unnecessary for a patient to suffer from the distressing symptoms of myxedema.
Most patients feel so much better that they must be warned against overexertion. This procedure does not alter the underlying pathological process, and so it is important that they should not overtax themselves. Three of our patients, because of economic necessity, are working eight to twelve hours a day. While this is not advisable under ideal circumstances, 2 of the patients are highly intelligent and although performing manual labor, one as a foreman of bricklayers, and the other as a laboratory assistant, they are careful to avoid intense effort.
The social-economic problems in our patients have been many. While some patients must be warned not to overdo, others have their previous suffering so vividly before them that they must be encouraged to develop self confidence and undertake moderate exercise. Fear of recurrence of angina pectoris or congestive failure in some patients presents a serious psychologic problem. Some patients, supported by other members of the family for years, are faced with the necessity of becoming self reliant and independent on being relieved of their angina pectoris or congestive failure.
PROBLEMS REQUIRING FURTHER STUDY
The final appraisal of this new therapeutic procedure awaits the results attained in numerous patients with various types of cardiovascular disease. Whether the duration of life is actually prolonged by this treatment can only be ascertained by studying the subsequent history of these patients over their entire clinical course. From our previous experience with total thyroidectomy, it would appear that in any case, duration of life is not shortened, and that undoubtedly many months of a worthwhile and comfortable existence already have been added to these invalided cardiac patients, many of whom have suffered greatly from recurrent attacks of angina pectoris, paroxysmal dyspnea, acute pulmonary edema, and the (istressing symptoms of congestive failure.
Our previous experience with total thyroidectomy, as well as the results in Case 8, indicate that concomitant diabetes mellitus is ameliorated as judged by the lessened insulin requirement.
The hypothyroid state involves complex relationships between the thyroid, pituitary, adrenals, gonads and other endocrines. In accordance with our previous experience with total thyroidectomy, we have observed in the hypothyroid state that some of our patients became less irritable and more stable emotionally, a fact which suggests that induction of myxedema may be helpful in the care of unmanageable, disturbed psychotic patients who require forcible feeding and constant restraint.
The marked variation displayed by different patients in the symptomatology of myxedema suggests that the effects of the hypothyroid state on the other endocrine glands may be responsible for some of these symptoms. If this proves to be the case, and if substitution therapy for the hypofunction of other endocrine organs can be given without raising the metabolic rate, some patients might be maintained in comfort at a lower and more beneficial metabolic rate. This problem is receiving further study by us and it is hoped that other investigators may also bend their efforts in this direction. 4. Each patient received orally a total of 25.5 to 150 millicuries in single or divided doses, of which a total of 7.3 to 39 millicuries was retained within the body during the following seventy-two hours. The largest single dose was 56 millicuries.
5. The average total dose was 54.4 millicuries; the average three day retention, 17.9 millicuries. 6 . Only patients were treated who w-ere seriously incapacitated despite all standard forms of therapy and marked restriction of activities for many months or years.
7. Angina pectoris has been strikingly lessened or abolished in 8 of the 13 patients with intractable cardiac pain. Several patients have been rehabilitated andl are gainfully employed. Concomitant congestive failure present in several of these patients was likewise improved. In the other 5 of the 13 patients, angina pectoris was greatly relieved when the patients were myxedematous but recurred when thyroid was administered to ameliorate the discomfort of myxedema.
8. Three of a patients incapacitated primarily because of congestive heart failure have shown worthwhile improvement; in 2 of these the improvement has been striking.
9. Tentative criteria for the selection of patients are presented, and the pre-and posttreatment management of the clinical course is described.
10. In the clinical management of these patients, we have attempted to maintain the lowest metabolic rate consistent with the comfort of the patient and have administered small doses of thyroid after the induction of myxedema.
11. This group represents the intractable cardiac cripples who are ordinarily considered for surgery. Hypothyroidism induced by radioactive iodine promises to accomplish worthwhile improvement through medical means without the inevitable risk and complications of surgical intervention.
12. This procedure is therefore proposed as a means of treating angina pectoris and congestive failure refractory to the standard medical measures and is submitted for further investigation by other workers in this field.
13. Final evaluation of this therapy must await prolonged study. At present it can be said that many months of worthwhile existence already have been added to the lives of these disabled cardiac patients who were refractory to all standard forms of medical therapy.
